Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

licensing opportunity oncology new class

Popular

Description

I have two promising novel classes of anticancer drugs with first in class attributes available for in licensing.

The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.

POC : In-vitro cytotoxicactivity on human cancer cells

A screening platform could be discussed as well

Please contact

Jean-Charles Brosse

e-mail :

jcharlesbrosse@aol.com

jcharlesbrosse@gmail.com

mobile : +33607832134 

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 676

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
764 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
629 Views
Profitable and Modern Russian CMO with long...
595 Views
Adalimumab API available: - from EU cGMP...
10338 Views
Infliximab API available: - from EU cGMP...
603 Views
Normal 0 false false false EN-US X-NONE HE /*...
588 Views
Start-up pharmaceutical company from South...
2038 Views